메뉴 건너뛰기




Volumn 90, Issue 3, 2016, Pages 1682-1686

Enhanced immune responses to HIV-1 envelope elicited by a vaccine regimen consisting of priming with newcastle disease virus expressing HIV gp160 and boosting with gp120 and SOSIP gp140 proteins

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 160; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR; DRUG CARRIER; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; GP140 ENVELOPE PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; GP160 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT VACCINE;

EID: 84958087541     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02847-15     Document Type: Article
Times cited : (12)

References (27)
  • 1
    • 23844451664 scopus 로고    scopus 로고
    • Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus
    • Forsell MN, Li Y, Sundback M, Svehla K, Liljestrom P, Mascola JR, Wyatt R, Karlsson Hedestam GB. 2005. Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus. J Virol 79: 10902-10914. http://dx.doi.org/10.1128/JVI.79.17.10902-10914.2005.
    • (2005) J Virol , vol.79 , pp. 10902-10914
    • Forsell, M.N.1    Li, Y.2    Sundback, M.3    Svehla, K.4    Liljestrom, P.5    Mascola, J.R.6    Wyatt, R.7    Karlsson Hedestam, G.B.8
  • 2
    • 0027462887 scopus 로고
    • Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein
    • Cooney EL, McElrath MJ, Corey L, Hu SL, Collier AC, Arditti D, Hoffman M, Coombs RW, Smith GE, Greenberg PD. 1993. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc Natl Acad Sci U S A 90:1882-1886. http://dx.doi.org/10.1073/pnas.90.5.1882.
    • (1993) Proc Natl Acad Sci U S A , vol.90 , pp. 1882-1886
    • Cooney, E.L.1    McElrath, M.J.2    Corey, L.3    Hu, S.L.4    Collier, A.C.5    Arditti, D.6    Hoffman, M.7    Coombs, R.W.8    Smith, G.E.9    Greenberg, P.D.10
  • 3
    • 33846087269 scopus 로고    scopus 로고
    • Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
    • Shu Y, Winfrey S, Yang ZY, Xu L, Rao SS, Srivastava I, Barnett SW, Nabel GJ, Mascola JR. 2007. Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. Vaccine 25:1398-1408. http://dx.doi.org/10.1016/j.vaccine.2006.10.046.
    • (2007) Vaccine , vol.25 , pp. 1398-1408
    • Shu, Y.1    Winfrey, S.2    Yang, Z.Y.3    Xu, L.4    Rao, S.S.5    Srivastava, I.6    Barnett, S.W.7    Nabel, G.J.8    Mascola, J.R.9
  • 4
    • 33846224780 scopus 로고    scopus 로고
    • Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein
    • Xu R, Srivastava IK, Greer CE, Zarkikh I, Kraft Z, Kuller L, Polo JM, Barnett SW, Stamatatos L. 2006. Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein. AIDS Res Hum Retroviruses 22: 1022-1030. http://dx.doi.org/10.1089/aid.2006.22.1022.
    • (2006) AIDS Res Hum Retroviruses , vol.22 , pp. 1022-1030
    • Xu, R.1    Srivastava, I.K.2    Greer, C.E.3    Zarkikh, I.4    Kraft, Z.5    Kuller, L.6    Polo, J.M.7    Barnett, S.W.8    Stamatatos, L.9
  • 5
    • 0142154176 scopus 로고    scopus 로고
    • Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease
    • Fultz PN, Stallworth J, Porter D, Novak M, Anderson MJ, Morrow CD. 2003. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Virology 315:425-437. http://dx.doi.org/10.1016/S0042-6822(03)00546-4.
    • (2003) Virology , vol.315 , pp. 425-437
    • Fultz, P.N.1    Stallworth, J.2    Porter, D.3    Novak, M.4    Anderson, M.J.5    Morrow, C.D.6
  • 9
    • 27144444664 scopus 로고    scopus 로고
    • Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates
    • Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, Murphy BR, Samal SK, Collins PL. 2005. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 79:13275-13284. http://dx.doi.org/10.1128/JVI.79.21.13275-13284.2005.
    • (2005) J Virol , vol.79 , pp. 13275-13284
    • Bukreyev, A.1    Huang, Z.2    Yang, L.3    Elankumaran, S.4    St Claire, M.5    Murphy, B.R.6    Samal, S.K.7    Collins, P.L.8
  • 10
    • 34547406849 scopus 로고    scopus 로고
    • Newcastle disease virus, a host rangerestricted virus, as a vaccine vector for intranasal immunization against emerging pathogens
    • DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2007. Newcastle disease virus, a host rangerestricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 104:9788-9793. http://dx.doi.org/10.1073/pnas.0703584104.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 9788-9793
    • DiNapoli, J.M.1    Kotelkin, A.2    Yang, L.3    Elankumaran, S.4    Murphy, B.R.5    Samal, S.K.6    Collins, P.L.7    Bukreyev, A.8
  • 11
    • 73949090729 scopus 로고    scopus 로고
    • Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys
    • DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2010. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84:1489-1503. http://dx.doi.org/10.1128/JVI.01946-09.
    • (2010) J Virol , vol.84 , pp. 1489-1503
    • DiNapoli, J.M.1    Nayak, B.2    Yang, L.3    Finneyfrock, B.W.4    Cook, A.5    Andersen, H.6    Torres-Velez, F.7    Murphy, B.R.8    Samal, S.K.9    Collins, P.L.10    Bukreyev, A.11
  • 12
    • 78649697847 scopus 로고    scopus 로고
    • Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
    • DiNapoli JM, Yang L, Samal SK, Murphy BR, Collins PL, Bukreyev A. 2010. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine 29:17-25. http://dx.doi.org/10.1016/j.vaccine.2010.10.024.
    • (2010) Vaccine , vol.29 , pp. 17-25
    • DiNapoli, J.M.1    Yang, L.2    Samal, S.K.3    Murphy, B.R.4    Collins, P.L.5    Bukreyev, A.6
  • 13
    • 35448972595 scopus 로고    scopus 로고
    • Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus
    • DiNapoli JM, Yang L, Suguitan A, Jr, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2007. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81:11560-11568. http://dx.doi.org/10.1128/JVI.00713-07.
    • (2007) J Virol , vol.81 , pp. 11560-11568
    • DiNapoli, J.M.1    Yang, L.2    Suguitan, A.3    Elankumaran, S.4    Dorward, D.W.5    Murphy, B.R.6    Samal, S.K.7    Collins, P.L.8    Bukreyev, A.9
  • 14
    • 84940870885 scopus 로고    scopus 로고
    • Mucosal immunization with Newcastle disease virus vector coexpressing HIV-1 Env and Gag proteins elicits potent serum, mucosal, and cellular immune responses that protect against vaccinia virus Env and Gag challenges
    • Khattar SK, Manoharan V, Bhattarai B, LaBranche CC, Montefiori DC, Samal SK. 2015. Mucosal immunization with Newcastle disease virus vector coexpressing HIV-1 Env and Gag proteins elicits potent serum, mucosal, and cellular immune responses that protect against vaccinia virus Env and Gag challenges. mBio 6:e01005. http://dx.doi.org/10.1128/mBio.01005-15.
    • (2015) mBio , vol.6
    • Khattar, S.K.1    Manoharan, V.2    Bhattarai, B.3    LaBranche, C.C.4    Montefiori, D.C.5    Samal, S.K.6
  • 15
    • 84929091266 scopus 로고    scopus 로고
    • Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus
    • Khattar SK, Palaniyandi S, Samal S, LaBranche CC, Montefiori DC, Zhu X, Samal SK. 2015. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus. Hum Vaccin Immunother 11:504-515. http://dx.doi.org/10.4161/21645515.2014.987006.
    • (2015) Hum Vaccin Immunother , vol.11 , pp. 504-515
    • Khattar, S.K.1    Palaniyandi, S.2    Samal, S.3    LaBranche, C.C.4    Montefiori, D.C.5    Zhu, X.6    Samal, S.K.7
  • 16
    • 80055018755 scopus 로고    scopus 로고
    • Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs
    • Khattar SK, Samal S, Devico AL, Collins PL, Samal SK. 2011. Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs. J Virol 85:10529-10541. http://dx.doi.org/10.1128/JVI.05050-11.
    • (2011) J Virol , vol.85 , pp. 10529-10541
    • Khattar, S.K.1    Samal, S.2    Devico, A.L.3    Collins, P.L.4    Samal, S.K.5
  • 17
    • 84884858409 scopus 로고    scopus 로고
    • Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated Newcastle disease virus vector
    • Khattar SK, Samal S, LaBranche CC, Montefiori DC, Collins PL, Samal SK. 2013. Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated Newcastle disease virus vector. PLoS One 8:e78521. http://dx.doi.org/10.1371/journal.pone.0078521.
    • (2013) PLoS One , vol.8
    • Khattar, S.K.1    Samal, S.2    LaBranche, C.C.3    Montefiori, D.C.4    Collins, P.L.5    Samal, S.K.6
  • 18
    • 84861307180 scopus 로고    scopus 로고
    • Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma
    • Sajadi MM, Lewis GK, Seaman MS, Guan Y, Redfield RR, DeVico AL. 2012. Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma. J Virol 86:5014-5025. http://dx.doi.org/10.1128/JVI.06547-11.
    • (2012) J Virol , vol.86 , pp. 5014-5025
    • Sajadi, M.M.1    Lewis, G.K.2    Seaman, M.S.3    Guan, Y.4    Redfield, R.R.5    DeVico, A.L.6
  • 19
    • 33847293391 scopus 로고    scopus 로고
    • Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1
    • Dey AK, David KB, Klasse PJ, Moore JP. 2007. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. Virology 360:199-208. http://dx.doi.org/10.1016/j.virol.2006.09.046.
    • (2007) Virology , vol.360 , pp. 199-208
    • Dey, A.K.1    David, K.B.2    Klasse, P.J.3    Moore, J.P.4
  • 21
    • 31144451337 scopus 로고    scopus 로고
    • Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
    • Li Y, Svehla K, Mathy NL, Voss G, Mascola JR, Wyatt R. 2006. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol 80:1414-1426. http://dx.doi.org/10.1128/JVI.80.3.1414-1426.2006.
    • (2006) J Virol , vol.80 , pp. 1414-1426
    • Li, Y.1    Svehla, K.2    Mathy, N.L.3    Voss, G.4    Mascola, J.R.5    Wyatt, R.6
  • 24
    • 33947590277 scopus 로고    scopus 로고
    • A comparative immunogenicity study in rabbits of disulfidestabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120
    • Beddows S, Franti M, Dey AK, Kirschner M, Iyer SP, Fisch DC, Ketas T, Yuste E, Desrosiers RC, Klasse PJ, Maddon PJ, Olson WC, Moore JP. 2007. A comparative immunogenicity study in rabbits of disulfidestabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120. Virology 360:329-340. http://dx.doi.org/10.1016/j.virol.2006.10.032.
    • (2007) Virology , vol.360 , pp. 329-340
    • Beddows, S.1    Franti, M.2    Dey, A.K.3    Kirschner, M.4    Iyer, S.P.5    Fisch, D.C.6    Ketas, T.7    Yuste, E.8    Desrosiers, R.C.9    Klasse, P.J.10    Maddon, P.J.11    Olson, W.C.12    Moore, J.P.13
  • 25
    • 0035155850 scopus 로고    scopus 로고
    • Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers
    • Yang X, Wyatt R, Sodroski J. 2001. Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol 75:1165-1171. http://dx.doi.org/10.1128/JVI.75.3.1165-1171.2001.
    • (2001) J Virol , vol.75 , pp. 1165-1171
    • Yang, X.1    Wyatt, R.2    Sodroski, J.3
  • 26
    • 4444342579 scopus 로고    scopus 로고
    • Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d
    • Bower JF, Yang X, Sodroski J, Ross TM. 2004. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. J Virol 78:4710-4719. http://dx.doi.org/10.1128/JVI.78.9.4710-4719.2004.
    • (2004) J Virol , vol.78 , pp. 4710-4719
    • Bower, J.F.1    Yang, X.2    Sodroski, J.3    Ross, T.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.